- Recent Funding
- Investors
- Rock Springs Capital
R
Rock Springs Capital
Rock Springs Capital has backed 1 company on Recent Funding, 0 in the last 12 months; its most recent deal is Parabilis Medicines (2024-03-01).
What Rock Springs Capital invests in
- Health and bio · 1 · 100%
How Rock Springs Capital invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series b+ | 1 100% | $145M |
Share is of the 1 round on Recent Funding that name Rock Springs Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio
| Company | Round with Rock Springs Capital | Total raised | Latest raise |
|---|---|---|---|
 PParabilis MedicinesHealth and bio |
Series b+ · $145M | $801M | Jan 8, 2026 Series b+ |
Most frequent co-investors
GGeneral Catalyst1 shared round · last Mar 1, 2024
- FFidelity Management & Research Company1 shared round · last Mar 1, 2024
- AARCH Venture Partners1 shared round · last Mar 1, 2024
- NNextech Invest1 shared round · last Mar 1, 2024
- RRA Capital Management1 shared round · last Mar 1, 2024
- SSamsara Biocapital1 shared round · last Mar 1, 2024
- AAlex Gorsky1 shared round · last Mar 1, 2024
Portfolio companies are the companies on Recent Funding with a round that lists Rock Springs Capital, which is a subset of its real portfolio. API: /api/v1/investors/rock-springs-capital. All investors.
Catch them early
Stealth builders and new accelerator batches, weekly.
Unsubscribe anytime · privacy